3030 — Test Research Income Statement
0.000.00%
Last trade - 00:00- TWD36.50bn
- TWD35.61bn
- TWD6.36bn
- 80
- 38
- 74
- 75
Annual income statement for Test Research, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,951 | 5,607 | 6,709 | 4,435 | 6,356 |
| Cost of Revenue | |||||
| Gross Profit | 2,715 | 3,048 | 3,849 | 2,631 | 3,784 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 3,513 | 4,049 | 4,555 | 3,227 | 4,326 |
| Operating Profit | 1,437 | 1,558 | 2,153 | 1,208 | 2,029 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,373 | 1,558 | 2,454 | 1,255 | 2,178 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,093 | 1,185 | 1,921 | 1,001 | 1,837 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,093 | 1,185 | 1,921 | 1,001 | 1,837 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 1,093 | 1,185 | 1,921 | 1,001 | 1,837 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.59 | 4.99 | 8.09 | 4.19 | 7.71 |
| Dividends per Share |